AuthorsMillen, G. C.
Cazier, J. B.
Grundy, R. G.
Lee, L. Y. W.
McCabe, Martin G
Stiller, C. A.
AffiliationCancer Research UK Clinical Trials Unit, University of Birmingham Institute of Cancer and Genomic Sciences, Birmingham, UK
MetadataShow full item record
AbstractBackground: Children with cancer are not at increased risk of severe SARS-CoV-2 infection; however, adults with haematological malignancies have increased risk of severe infections compared with non-haematological malignancies. Methods: We compared patients with haematological and non-haematological malignancies enrolled in the UK Paediatric Coronavirus Cancer Monitoring Project between 12 March 2020 and 16 February 2021. Children who received stem cell transplantation were excluded. Results: Only 2/62 patients with haematological malignancy had severe/critical infections, with an OR of 0.5 for patients with haematological compared with non-haematological malignancies. Interpretation: Children with haematological malignancies are at no greater risk of severe SARS-CoV-2 infection than those with non-haematological malignancies.
CitationMillen GC, Arnold R, Cazier J-B, Curley H, Feltbower R, Gamble A, et al. COVID-19 in children with haematological malignancies. Arch Dis Child. 2021 Jul 22;archdischild-2021-322062.
JournalArchives of Disease in Childhood
- Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titers.
- Authors: Šušol O, Hájková B, Zelená H, Hájek R
- Issue date: 2022 Jan 25
- Is COVID-19 less severe in CML patients than in those with other haematological cancers?
- Authors: Claudiani S
- Issue date: 2022 Feb